![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 11, 2024 5:47:41 PM
https://www.linkedin.com/posts/andrewpearce_andrew-bridgen-mp-abridgen-on-x-activity-7171096018267131904-dnT4
This is of significant relevance to Humanigen, as an appropriate Regulatory response would include the authorization and approval of lenzilumab to treat covid prophylactically as a vaccine adjuvant, and therapeutically.
The safety and efficacy of lenz has resulted in meeting the primary endpoint in the company-sponsored LIIVE-AIR trial, and the results have been peer-reviewed by both Lancet and Thorax.
https://www.humanigen.com/
Novel presentations of blood clots, including long white fibrous strands of blood clots, are being discovered in the bodies of patients who had multiple mRNA vaccinations. They have also resulted in covid spike proteins located in organs such as the brain and heart. as shown in the following videos.
I hope that Texas Attorney General Ken Paxton will also look into this.
"In patients diagnosed with covid pneumonia, and treated with lenzilumab, what is the recurrence rate of those patients presenting with SARS-CoV-2 nucleocapsid proteins after treatment?"
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM